Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the comparative effectiveness and safety of prophylactic cyclo-oxygenase inhibitor (COX-I) drugs (indomethacin, ibuprofen, or acetaminophen) and 'no COX-I prophylaxis' in preterm infants, using a Bayesian network meta-analysis.

Cite

CITATION STYLE

APA

Mitra, S., Gardner, C. E., MacLellan, A., Disher, T., Styranko, D. M., Kuhle, S., … Dorling, J. (2021). Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis. Cochrane Database of Systematic Reviews, 2021(1). https://doi.org/10.1002/14651858.CD013846

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free